Chemotherapeutic potentials of β‐ionone against Trypanosoma congolense infection: Inhibition of parasite proliferation, anemia development, trans‐sialidase (TconTS3 and TconTS4) gene expressions, and phospholipase A2.

MLA

Aminu, Suleiman, et al. “Chemotherapeutic Potentials of Β‐ionone against Trypanosoma Congolense Infection: Inhibition of Parasite Proliferation, Anemia Development, Trans‐sialidase (TconTS3 and TconTS4) Gene Expressions, and Phospholipase A2.” Chemical Biology & Drug Design, vol. 99, no. 6, June 2022, pp. 908–22. EBSCOhost, https://doi.org/10.1111/cbdd.14048.

APA

Aminu, S., Ibrahim, M. A., Dada Chechet, G., & Onyike, E. (2022). Chemotherapeutic potentials of β‐ionone against Trypanosoma congolense infection: Inhibition of parasite proliferation, anemia development, trans‐sialidase (TconTS3 and TconTS4) gene expressions, and phospholipase A2. Chemical Biology & Drug Design, 99(6), 908–922. https://doi.org/10.1111/cbdd.14048

Chicago

Aminu, Suleiman, Mohammed Auwal Ibrahim, Gloria Dada Chechet, and Elewechi Onyike. 2022. “Chemotherapeutic Potentials of Β‐ionone against Trypanosoma Congolense Infection: Inhibition of Parasite Proliferation, Anemia Development, Trans‐sialidase (TconTS3 and TconTS4) Gene Expressions, and Phospholipase A2.” Chemical Biology & Drug Design 99 (6): 908–22. doi:10.1111/cbdd.14048.